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Abstract. The NEM-sensitive fusion protein,  NSF, to- 
gether with SNAPs (soluble NSF attachment proteins) 
and the SNAREs (SNAP receptors), is thought to be 
generally used for the fusion of transport vesicles to 
their target membranes.  NSF is a homotrimer whose 
polypeptide subunits are made up of three distinct do- 
mains:  an amino-terminal  domain (N) and two homol- 
ogous ATP-binding domains (D1 and D2).  Mutants of 
NSF were produced in which either the order or com- 
position of the three domains were altered.  These mu- 
tants could not support intra-Golgi transport,  but they 
indicated that the D2 domain was required for trimeri- 
zation of the NSF subunits.  Mutations of the first 
ATP-binding  site that affected either the binding 
(K266A) or hydrolysis (E329Q) of ATP completely 
eliminated NSF activity. The hydrolysis mutant was an 
effective, reversible inhibitor of Golgi transport with 
an IC50 of 125  ng/50 #1 assay.  Mutants in the second 
ATP-binding  site (binding,  K549A; hydrolysis, 
D604Q) had either  14 or 42 % the specific activity of 
the wild-type protein,  respectively. Using coexpression 
of an inactive mutant with wild-type subunits,  it was 
possible to produce a  recombinant form of trimeric 
NSF that contained a mixture of subunits.  The mixed 
NSF trimers were inactive, even when only one mu- 
tant subunit was present,  suggesting that NSF action 
requires each of the three subunits in a concerted 
mechanism.  These studies demonstrate that the ability 
of the D1 domain to hydrolyze ATP is required for 
NSF activity and,  therefore is required for membrane 
fusion.  The D2 domain is required for trimerization, 
but its ability to hydrolyze ATP is not absolutely re- 
quired for NSF function. 
I 
NTERCISTERIqAL Golgi transport is a multistep  process 
(36).  Initially,  transport  vesicles carrying  cargo pro- 
teins bud from their compartment of origin.  Both the 
forming buds and resulting vesicles are coated with a seven- 
protein complex known as coatomer (29, 30, 32, 51), and the 
small molecular weight GTP-binding protein, ADP ribosyla- 
tion factor (40).  The coated vesicles move to their target 
compartment, they are uncoated in a process that requires 
GTP hydrolysis by ADP ribosylation factor (47),  and dock 
with the target membrane. Finally, the vesicles fuse with and 
release their cargo into their target compartment.  Vesicle- 
target membrane fusion is inhibited  by the alkylating  agent 
N-ethylmaleimide  (NEM)  ~ (2,  16, 25), a property that was 
exploited to purify the  NEM-sensitive component of the 
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transport process from CHO cell cytosol (5).  The protein 
thus  purified  was  named  NEM-sensitive  fusion  protein 
(NSF) because of its apparent role in membrane fusion (25). 
Kinetic studies indicate that NSF acts late in transport,  and 
morphometric  experiments  show  that  NEM  treatment  of 
Golgi membranes causes a  buildup of uncoated transport 
vesicles that are consumed after the addition of the pure NSF 
protein (25). NSF is also required in several intracellular  fu- 
sion events such as ER-to-Golgi transport (3),  endosome- 
endosome fusion (10),  and transcytotic vesicles-to-plasma 
membrane transport  (45).  The NSF homologue in yeast, 
SEC18p (55), is involved in several transport events such as 
ER-to-Golgi and Golgi-to-plasma membrane transport (17). 
These data taken together suggest that NSF is a general com- 
ponent of the intracellular  fusion machinery. 
NSF, in its active form, is a homooligomeric protein con- 
sisting of 76-kD subunits as determined by SDS-PAGE (5). 
The cDNA encoding NSF shows that each subunit contains 
two consensus ATP-binding sites (55) consisting of a Walker 
A box motif (50) and a permutation of the Walker B motif 
known as the DEAD box (24). These two ATP-binding sites 
are homologous to those of a family of ATP-binding proteins 
(22).  These proteins contain either one or two conserved 
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functions. Like other members of this family, NSF possesses 
an ATPase activity with a high pH optimum, pH 9.0 (33, 46). 
Sequence analysis of NSF suggested that it could be sepa- 
rated into three distinct domains: an amino terminal (N) fol- 
lowed by the two homologous ATP-binding (D1, D2)  do- 
mains (55).  Limited proteolysis showed that the predicted 
domain boundaries do indeed correspond to structural ele- 
ments of the NSF molecule (46). 
NSF is a soluble cytosolic protein that binds transiently to 
membranes in an ATP-dependent fashion (53). This associa- 
tion is mediated by a set of proteins called soluble NSF at- 
tachment proteins (SNAPs) (8). Two of the forms, alpha and 
gamma,  are  expressed  in  all  tissues  and  have been  im- 
munolocalized to  several  subcellular compartments (54), 
suggesting that they too are general fusion components. NSF 
and SNAPs stably associate with integral-membrane protein 
receptors, SNAP receptors (SNAREs), when ATP hydroly- 
sis is prevented (57).  This property allowed the purification 
of a  detergent-soluble particle made up of SNAREs from 
both vesicle and target membranes, as well as stoichiometric 
amounts of SNAPs and NSF (42).  The particle assembles 
when ATP hydrolysis is prevented (ATY3,S or EDTA/ATP) 
and  disassembles  under  hydrolytic conditions  (42,  57). 
Since NSF is the only protein in the complex that binds ATE 
it is likely that the assembly/disassembly cycle of this 20S 
docking/fusion complex  is  governed  by  ATP  hydrolysis 
by NSF. 
In this manuscript, we present the first data directly dem- 
onstrating the critical role of ATP hydrolysis by NSF  in 
membrane fusion. We also demonstrate that NSF is a homo- 
trimer. Each subunit is made up of three distinct domains 
that appear to be responsible for different aspects of NSF 
function in the fusion event. The first ATP-binding site is ab- 
solutely  required  for  fusion,  and  the  second  domain  is 
needed for trimerization. Additionally, it is demonstrated 
that all three subunits must be active to form an active NSF 
trimer. This observation suggests  the NSF may use a con- 
certed mechanism to facilitate membrane fusion. 
Materials and Methods 
Production of  Domain Switch Mutants 
To produce mutant proteins in which the domain structure of NSF was 
changed, PCR primers were designed to produce DNA fragments encoding 
the isolated NSF domains with BamHI and XhoI cloning sites for insertion 
into pKS H  + Blue.script (Stratagene,  La Jolla, CA). The PCR primers were 
constructed to include restriction sites that would  maintain the reading 
frame after blunt end ligation.  DNA fragments encoding the isolated do- 
mains can be combined by blunt-end ligation in any order or combination 
to create the desired form of NSF. The ligation joints were checked by 
dideoxy  sequencing using Sequenase  (United States Biochemical Corp., 
Cleveland, OH), and the constructs were cloned into the BamHI/Sall sites 
of the pQE-9 expression vector (Qiagen,  Chatsworth,  CA). 
Production of  ATP-binding Site Mutants 
Point mutations to change the residues of  the ATP-binding sites were created 
by the overlapping  PCR technique (18). Briefly, two complementary PCR 
primers, each of which contains the desired mutation, are used with appro- 
priate flanldng primers to generate two short PCR products that contain the 
mutation in their overlapping regions. These PCR products were then dena- 
tured, annealed to each other, and a "full-length" product that contains an 
internal mutation was amplified using the flankins primers. New mutagene- 
sis primers were made for each mutation, but the same outer primers were 
used for all constructs of the same domain. The outer primers were chosen 
to make use of endogenous restriction sites in the NSF DNA (EcoNl/ClaI 
for the domain 1 ATP-binding site and BstEII/Bsu36I for the domain 2 ATP- 
binding site). Once a piece of the coding region was mutated by PCR and 
confirmed by dideoxy  sequencing,  it was cloned into an NSF expression 
construct. After generating the single-site  mutations, a double mutant in 
which both ATP-binding sites are changed was made by simple restriction 
digestion and ligation. NSF constructs were cloned into the BamHI/SalI site 
of the pQE-9 plasmid, allowing high levels of expression of the NSF mu- 
tants with a hexahistidine  tag at the amino terminus. The plasmids were 
transformed into XL-1 Blue Escherichia coli (Stratagene),  and colonies 
were selected based on resistance to ampicillin and tetracycline,  as well as 
their ability to express the NSF construct. 
Production of  Mixed NSF Oligomers 
To produce the mixed oligomers of NSF, it was necessary to construct an 
expression plasmid that could be used in the same cells with pQE-9.  This 
expression vector was generated by replacing the promotor,  operator, and 
ribosome-binding  sites of the plasmid pMON5839 (11, 28) with those of the 
plasmid pQE-3 (Qiagen).  Initially, the pMON5839 was modified by delet- 
ing its unique BamHI site by digestion with BamHI, filling in the sticky ends 
with DNA polymerase I (Klenow  fragment; Boehringer Mannheim Bio- 
chemicals, Indianapolis,  IN), and religation.  This modified plasmid was cut 
with BglII, filled in to blunt ends with DNA polymerase I, and then cut with 
Sail to delete its promotor, operator, and ribosome-binding sites. The anal- 
ogous region of pQE-3 (Qiagen)  was excised by digestion  of the plasmid 
with XhoI, filling in to blunt ends with DNA polymerase I, and Sail diges- 
tion. This promotor,  operator, and ribosome-binding region of pQE-3 was 
then ligated into the blunt/SalI sites of the modified pMON5839.  The final 
construct, called pMONQE, contains the kanumycin resistance gene from 
the pMON5839 plasmid and the cloning sites of the pQE-3 plasmid but with 
no Hist-tag. The wild-type NSF construct was cloned into this plasmid, 
cotransforrned with the K266A NSFmyc construct in pQE-9 (Qiagen),  and 
cotransformants  were selected by resistance to ampicillin, tetracycline,  and 
kanamycin. These cotransformants  expressed approximately equal amounts 
of NSF subunits from each plasmid (data not shown).  This coexpression 
was used to generate NSF oligomers  that contain two different  types of 
subunits that could be detected with anti-NSF (6E6) and anti-myc epitope 
(9El0) monoclonal antibodies. 
Purification of  NSF and NSF Mutants 
A purification  scheme for wild-type and mutant forms of NSF, based on 
published procedures for the purification of Hist-tagged  proteins and NSF, 
was used (54). Cells expressing the appropriate  construct were grown to a 
density of At00 =  0.8 in Super medium (25 g bacto-tryptone, 15 g yeast 
extract, and 5 g NaCl/liter with 100/~g/ml ampicillin and 50 ~tg/ml tetracy- 
cline) and induced for 4 h with 1 mM isopropyl-thio-/~-D-galactoside. The 
cells were harvested by centrifogation,  and they were washed in breaking 
buffer (100 mM Hepes/KOH,  pH 7.0, 500 mM KCI, 5 mM ATP, 5 raM 
MgC12, 2 mM 2-mercaptoethanol, 2 mM PMSF,  10 ~g/ml leupeptin, and 
1 ~tM pepstatin).  The pellet was resuspended in 1/60 of the original volume 
in Breaking buffer and disrupted by French press. The extract was clarified 
by centrifugation at 250000 g for I h, and the supernatant was loaded onto 
a Ni2+nitrilotriacetic acid (NTA) agarose (19) (Qiagen) column (5 ml) that 
was equilibrated in 20 mM Hepes/KOH,  pH 7.0, 200 mM KC1, 2 mM 
2-mercaptoethanol, 0.5 mM ATP, 1 mM MgCI2, and 10% glycerol (buffer 
A). After loading,  the column was washed with three column volumes of 
buffer A, three column volumes of buffer A +  20 mM imidazole,  and was 
then eluted with an eight-column  volume gradient of buffer A from 20 to 
500 mM imidazole. NSF elutes at an imidazole concentration of ,~ 200 mM 
and in most cases  is >80%  pure.  Additional  purification (>95%) was 
achieved by gel filtration  chromatography on a Superose 6 Fast Flow (Phar- 
macia Diagnostics  Inc., Farifield,  NJ) column (1.6 ×  50 cm) in 50 mM 
Hepes/KOH,  pH 7.8, 100  mM KCI,  2  mM 2-mercaptoethanol,  1 mM 
MgCI2, 0.5 mM ATP, and 5% glycerol. 
In Vitro intercisternai Golgi transport assays 
NSF activity was measured as outlined in Block et al. (5). Briefly, the en- 
dngenous NSF from donor and acceptor Golgl membranes was inactivated 
by treatment for 15 rain on ice with 1 mM NEM and was quenched with 
2  mM  DTT.  These  membranes  were  then  used  together  with  heat- 
inactivated CHO cells cytosol (that lacks NSF activity) in a standard trans- 
port assay incubated for 1.5 h at 37°C. The reaction was stopped, and the 
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from the donor to acceptor compartment was recovered as described (1) and 
quantitated by liquid scintillation counting.  To determine the specific activ- 
ity of some of the mutant forms, a time course experiment in which aliquots 
of the transport assay were taken at different times was used.  The rate of 
transport was calculated based on counts per minute of [3H]N-acetyl-gh- 
cosamin-VSV-G produced per minute after the initial 10-min lag. 
ATPase Assays 
NSF and the mutant forms were tested for ATPase activity using the tech- 
nique described in Tagaya et al. (46). [c~32p]ATP  (3,000 Ci/mmol) was pur- 
chased from Du Pont NEN (Wilmington, DE).  Briefly, wild-type or mu- 
tant NSF  (1  pg/20 pl)  was  incubated in buffer (0.77 mM ATE  8  /~Ci 
[c~32P]ATP; 25 mM Tris/HCl, pH 9.0, 100 mM KCI, 0.5 mM DTT, 0.65 
mM mercaptoethanol, 1 mM MgC12, 10% glycerol) for 1.5 h at 370C. 1 #1 
of the reaction was then spotted  in duplicate  onto cellulose polyethylene- 
imine thin-layer chromatography plates (MN 300; Brinkmarm Instruments, 
Inc., Westbury, NY) and developed in 0.7 M LiC1, 1 M acetic acid. After 
exposure of the thin layer plates to x-ray film, the la32PlADP spots were 
identified relative to standards, cut out of the plate, and counted by liquid 
scintillation.  The amount of [oP2p]ADP produced was compared for sam- 
pies that had been either treated or not with 4.95 mM NEM (threefold ex- 
cess over sulfhydryl groups).  NEM treatment has been shown to completely 
abolish the ATPase activity ofNSE NEM treatment was used in these assays 
to distinguish the NSF-specific ATPase activity from that of contaminating 
phosphatases. 
Velocity Sedimentation on Glycerol  Gradients 
Wild-type  and mutant NSF were analyzed by velocity sedimentation on 
glycerol gradients using a modification of the method described in Wilson 
et al. (57). 50/~g of protein were loaded onto a 5.0-ml linear glycerol gra- 
dient (10-35%) in 20 mM Hepes/KOH,  pH 7.0, 100 mM KC1, 2  mM 
MgCI2, 2 mM DTT, and 0.5 mM ATP. The gradients were then subjected 
to centrifugation for 14 h at 4*C at a speed of 29,000 rpm in a rotor (SW-55; 
Beckman Instruments, Inc., Spinco Division, Palo Alto, CA).  The gra- 
dients were harvested (at 330 td/min) from the bottom into 15 fractions, 
and aliquots were analyzed by SDS-PAGE. The velocity sedimentation  stan- 
dards were bovine serum albumin (4.6 S), cataiase (11.4 S), and ¢~2-macro- 
globulin (19.6 S). 
Sedimentation Analysis of  NSF 
Sedimentation analysis  was  performed  in  an analytical ultracentrifuge 
(model E; Beckman Instruments, Inc., Palo Alto, CA) equipped with a 
high-intensity  light source and a ultraviolet scanning system. Double-sector 
cells (12 mm path length) with sapphire windows were used in an AnG rotor. 
To  detect  possible  concentration-dependent dissociation,  the  meniscus 
depletion technique (58) was applied using an initial concentration of 0.3 
and 1.7 mg/ml for NSF and NSFmyc,  respectively.  The temperature was 
kept at 2°C and 12°C, and the scanning wavelengths were 230 and 280 nm, 
respectively. 
s values were determined at 24,000 rpm, plotting In r vs time, and cor- 
reefing for 200C and water viscosity. Sedimentation equilibria at 8,000 rpm 
were evaluated from In c vs r 2 plots, making use of computer programs de- 
veloped by A. Minten, National Institutes of Health ('Bethesda, biD), and 
G.  Boehm 0nstitut flit Biophysik  und Physikalische  Bioehemie,  Regens- 
burg, Germany). The partial specific volume was calculated from the amino 
acid composition. 
Cross-linking of  the NSF Oligomer 
NSF (0.36  mg/ml) was  cross-linked with various concentrations (0.1-10 
raM) bis(sulfosuccinimidyl)  suberate (BS3; Pierce Chemical Co.,  Rock- 
ford, IL) in 20 mM Hepes/KOH,  pH 7.4, 200 raM KCI, 0.14 mM ATP, 0.28 
mM DTT, and 3 % glycerol for 30 rain on ice. The reactions were quenched 
with 100 mM glycine, pH 7.4, and the cross-linked species were separated 
by SDS-PAGE on a 5 % acrylamide gel. 
Miscellaneous Techniques 
Protein concentrations were determined using the Bio Rad protein assay re- 
agent (Bio Rad Laboratories, Richmond, CA) and ovnibumin as a standard. 
Western  immunoblott~g was  visnalized using  horseradish peroxidase- 
coupled anti-mouse immunnglobulin secondary antibodies (Bio Rad Lab- 
oratories) and enhanced chemiluminescence reagents  (Amersham Corp., 
Arlington Heights, IL). SDS-PAGE gels were prepared and run as described 
(23) and stained with Coomassie brilliant blue R-250. 
Results 
Rationale of  Mutant Construction 
The sequence of the NSF subunits contains several features 
of interest:  specifically, two consensus ATP-binding sites 
(centered around residues 266  and 549)  and an apparent 
tridomain structure consisting of an amino-terminal domain 
(1-206) and the two homologous ATP-binding domains (207- 
487, 488-744).  The ATP-binding site sequences have been 
found in other proteins and used as a criterion for inclusion 
into a family  of  cellular ATPases found in a number of  organ- 
isms (22). The predicted domain structure was demonstrated 
by the fact that the individual domains of NSF can be gener- 
ated by limited proteolysis (46).  To understand the role of 
these domains in the function and structure of NSF, we con- 
structed a series of rearrangement mutants in which the or- 
der and composition of the domains in the NSF subunit were 
changed (see Materials and Methods and Fig.  1).  Specifi- 
cally, we were interested in what elements of the NSF sub- 
unit were involved in oligomer formation and what was re- 
quired for its function in Golgi transport. 
ATP hydrolysis by NSF has been proposed to play a cen- 
tral role in the fusion of vesicles with their target mem- 
branes.  To directly determine whether ATP hydrolysis by 
NSF is required for intercisternal Golgi transport and to 
delineate the relative roles of the two ATP binding domains, 
site-directed mutagenesis was used to change the conserved 
lysine residues (266, 549) in the G/A-X-X-X-X-G-K-T/S se- 
quences of the two Walker A boxes (50) and acidic amino 
acids (E329 or D604)  in the DEAD box elements of the 
Walker B boxes (24).  The conserved lysine residues (part of 
the P-loop [37]) have been reported to be involved in nucleo- 
tide binding in a number of ATP- and GTP-binding proteins, 
and their mutation is expected to yield an NSF subunit with 
reduced ATP-binding capacity. These lysine residues were 
changed to aianines since that switch has been calculated to 
cause the least structural perturbation to the polypeptide 
chain (6). The DEAD box motif  was originally seen in RNA 
helicases, which use ATP hydrolysis to unwind RNA for 
translation (38). The first two acidic amino acids are thought 
to  bind the  Mg  2+  ion that coordinates the phosphates  of 
ATP  for hydrolysis (31).  Replacement of either of these 
residues with a  positively charged amino acid eliminates 
ATP hydrolysis without affecting nucleotide binding in RNA 
helicases (35).  This series of DEAD box mutants is more 
likely to retain the ability to assume any change in tertiary 
structure that might be induced by ATP binding than would 
the lysine to alanine mutants discussed above. 
Characterization of  Domain Rearrangement 
Mutants of  NSF 
Plasmids encoding the domain rearrangement mutants were 
constructed by blunt end ligation of the separate domain- 
encoding  DNA  fragments  as  outlined  in  Materials  and 
Methods. The ligation joints were sequenced to ensure that 
the correct reading frame was maintained. These constructs 
were  then  cloned  into  pQE-9,  and  Hiss-tagged  proteins 
were produced in E. coli and purified by Ni2+NTA agarose 
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(Fig. 1 A), some of  the rearrangement mutants suffered from 
increased proteolysis during their preparation, especially the 
mutants in which a domain was repeated, eg., N-D1-D1 and 
N-D2-D2. This may reflect a lack of stability of the mutant 
proteins in the E.  coli cell. 
Initially, the mutant forms of  NSF were analyzed by veloc- 
ity sedimentation to determine whether they contained the 
molecular information needed to form homooligomers. Be- 
cause of the small size of the gradients, the accuracy of the 
size estimates is limited, but as is shown in Fig. 1 B, oligo- 
meric wild-type NSF can be easily separated from mono- 
meric mutant forms. From Table I, it is clear that all of the 
mutant forms that lacked the D2 domain were incapable of 
forming proper oligomeric  structures.  The  N-D1-D1  and 
N-D1 migrated only a short distance on the velocity gradient 
with an apparent size of 6 S. Mutants that contained the D2 
domain migrated with an s value similar to wild-type NSF. 
These data  suggest  that  the  second  ATP-binding domain 
(D2) of NSF is required for the oligomerization of the NSF 
subunits.  The prominent proteolysis fragment  ('~50  kD) 
present in the N-D2-D2 preparation, despite containing the 
2C8 epitope (see below), did not migrate as an oligomeric 
species. These mutant proteins were next tested in an NSF- 
dependent intra-Golgi transport assay.  While the wild-type 
NSF saturated the assay at 5 ng per 50 #l assay, none of the 
mutants had any transport activity using up to 40 ng per as- 
say (see Table I). This would indicate that the rearrangement 
mutants have less than one eighth of the activity of the wild- 
type protein, and they are considered inactive in intra-Golgi 
transport. 
Transport Activity of  ATP-binding Site Mutants 
of  NSF 
Point mutations of amino acids in the ATP-binding sites of 
NSF were made by PCR mutagenesis and were sequenced 
to insure that only the desired mutation was made. The mu- 
tant proteins were expressed in E. coli and were purified by 
Ni2+NTA agarose chromatography, followed by sizing chro- 
matography on Superose 6 (see Fig. 2 A). The elution posi- 
tion on Superose 6 (~300 ld)) insured that all of  the mutants 
were oligomeric. The proteolysis fragments in the D604Q 
preparation appeared after storage of the pure protein and 
were not initially present after purification. 
Mutant proteins were assayed in an NSF-dependent, intra- 
Golgi transport assay to assess the effect  that the point muta- 
tions in the two ATP-binding sites had on NSF activity (Fig. 
2, B and C). Mutations made in the first ATP-binding site 
(D1) led to a completely inactive form of NSE Two distinct 
mutations, K266A and E329Q, expected to affect ATP bind- 
ing and hydrolysis, respectively, resulted in the complete in- 
activation of the NSF produced. While wild-type NSF and 
Table L  Summary of the NSF Domain 
Rearrangement Mutants 
Mutant  Oiigomeric  s Value*  Activity* 
Wild-type  +  14.1  100% 
N-D2-D1  +  12.9  0% 
N-DI-D1  -  6  0% 
N-D2-D2  +  12.9  0% 
N-DI  -  6  0% 
D1-D2  +  12.9  0% 
Construction of the different NSF configurations is discussed in Materials and 
Methods.  The  mutant proteins were  expressed in E.  coli  and  purified  by 
Ni2+NTA agarose chromatography. 
* The purified proteins were analyzed by velocity sedimentation on a glycerol 
gradient and compared to standard proteins to determine their s values (see Fig. 
2 b). s values are given in Svedberg units, S. 
The purified proteins were tested for NSF activity by titration into a standard 
transport  assay  (50  #1  assay)  using  NEM-treated  membranes  and  heat- 
inactivated CHO cell cytosol (see Materials and Methods). 
l~gure 1. Characterization of the NSF domain rearrangement mu- 
tants. Domain rearrangement mutant constructs were produced and 
expressed in E.  coli as described in Materials and Methods. The 
proteins were purified by affinity chromatography on Ni2+NTA 
agarose. Approximately equal amounts of NSF or the mutants were 
separated by SDS-PAGE  and stained with Coomassie brilliant blue 
(A). Wild-type NSF and the N-D1-D1 mutant were analyzed by ve- 
locity sedimentations as described. Gradients were loaded on the 
top (right side ofthe panel) and subjected to centrifugation as de- 
scribed (B). The gradients were fractionated from the bottom (/eft 
side ofpanel), and aiiquots of each fraction was analyzed by SDS- 
PAGE on an 8% acrylamide gel and stained with Coomassie bril- 
liant  blue.  The sedimentation  standards  are  c~2-macroglobulin, 
19.6 S; catalase, 11.4 S; and bovine serum albumin, 4.6 S. The mo- 
lecular mass standards are pbospborylase B, 97.4 kD; bovine serum 
albumin, 66.2 kD; and ovalbumin, 45 kD. 
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Figure 2. Characterization of  the ATP binding site mutants of NSE 
Point mutations in both ATP binding sites of NSF were made as 
described in Materials and Methods. The proteins were purified by 
Ni2+NTA affinity chromatography and gel exclusion chromatogra- 
phy on Superose 6. Approximately equal amounts of  NSF or mutant 
proteins were analyzed by SDS-PAGE  on an 8 % acrylamide gel and 
Coomassie brilliant blue staining (A). The molecular mass stan- 
dards  were myosin, 200 kD;  ~-galactosidase,  116.2 kD;  phos- 
phorylase B, 97.4 kD; bovine serum albumin, 66.2 kD; and ovalbu- 
min, 45 kD. The mutants were then assayed for NSF activity in a 
standard transport  assay (50 t~l) using NEM-treated membranes 
NSFmyc saturated the transport assay at 5 ng/50 #I (authen- 
tic CHO cell NSF saturates at 2.6 ng per 50-/~1 assay [5]), 
the two D1 mutants showed no transport activity when used 
up to 20 ng/50 #1. Since the mutations were made in two dis- 
crete regions of the ATP-binding site, the inactivation that 
they cause is more likely a result of the effect on ATP bind- 
ing/hydrolysis rather than conformational alterations. These 
results demonstrate that the ability of D1 to hydrolyze ATP 
is required for the function of NSE 
Mutations in the second ATP-binding site resulted in an 
attenuated form of NSF that could support intra-Golgi trans- 
port albeit less effectively than wild-type protein (Fig. 2, B 
and  C).  The  two  mutations  K549A  and  D604Q  yielded 
forms of NSF that apparently saturate the transport assay at 
a concentration four times higher than wild-type NSF, and 
they supported only a fraction of the total transport (36 % for 
K549A, 64 % for D604Q). The specific activity of transport 
for these two mutants was determined by measuring the rate 
of NSF-dependent transport vs incubation time, and it was 
14 % (for K549A) and 42 % (for D604Q) that of  the wild-type 
NSE Because of the presence of proteolysis fragments in the 
D604Q preparation, the specific activity measured could be 
an underestimate. The relative difference in specific activity 
between the binding (K549A) and hydrolysis (D604Q) mu- 
tants was consistent in two different preparations of the mu- 
tant proteins (data not shown). Perhaps, the ATP binding to 
D2 may be needed to induce an appropriate conformation in 
the NSF molecule. These results demonstrate that the ability 
of the D2 domain to hydrolyze ATP is not absolutely re- 
quired for NSF function. Whatever the role of this D2 do- 
main in NSF function, its ability to at least bind ATP appears 
to be critical. As expected, the double hydrolysis mutant in 
which both E329 and D604 were changed to glutamine had 
no NSF activity. 
ATPase Activity of  ATP-binding Site Mutants 
The ATPase activity of NSF has two characteristics:  it is 
maximally active at pH 9.0, and it is completely eliminated 
by  treatment  of the  protein  with  N-ethylmaleimide  (46). 
These properties were exploited in measuring the ATPase 
activity of the ATP-binding site mutants.  Assays were per- 
formed at pH 9.0, and the ATPase activity was expressed as 
NEM sensitive, to distinguish it from contaminating phos- 
phatases that might be present in the various preparations of 
mutant NSE 
Mutations in either domain led to an overall decrease in 
the NEM-sensitive ATPase activity of the mutant Woteins 
compared to wild-type (see Fig. 3). Mutation in the D1 do- 
main had the greatest effect, causing a 69 and 82 % decrease 
in ATPase activity for the E329Q  and K266A mutations, 
respectively. Mutations in the D2  domain were not as ef- 
fective at  eliminating  ATPase activity (28%  decrease for 
D604Q and 41% decrease for K549A), suggesting that the 
D1  domain  accounts  for the  major  portion of the  NEM- 
and heat-inactivated CHO cell cytosol (B and C) (see Materials and 
Methods). Wild-type NSF and NSF with the COOH-terminal myc 
epitope (NSF and NSFmyc) were used as controls, and the mutants 
are denoted by the amino acid changed (as in D604) and what it 
was changed to (e.g.,  Q). 
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completely lacked ATPase activity. The one rearrangement 
mutant tested (N-D2-D1) had 77 % of wild-type ATPase ac- 
tivity. Since this mutant was inactive in intra-Golgi trans- 
port, it is clear that correct positioning of the domains, as 
well as ATPase activity, are required for NSF activity. 
Inhibition of  lntra-Golgi Transport by NSF Mutants 
Mutants that were inactive in the transport assay were tested 
to determine whether they could effectively inhibit intra- 
Golgi transport in a reversible fashion. Fig. 4 A shows the 
results  of an experiment in  which the mutant NSF  were 
titrated into a  transport assay.  The amount of endogenous 
NSF in a standard transport assay is estimated to be <5 ng 
per 50-/zl assay. The E329Q and the E329/D604Q mutants 
inhibited transport with ICso'S of 125 and 170 ng per 50-#1 
assay. The K266A mutant also inhibited the transport assay 
but required 2 #g per 50-tzl assay to achieve 50% inhibition 
(data not shown).  The inhibitory action of these mutants 
were completely reversed by the addition of  2/,g of wild-type 
NSF (Fig. 4 B and data not shown). These data indicate that 
the mutant NSF's can compete with endogenous NSF for 
binding to appropriate sites on the Golgi membranes. The 
domain  rearrangement mutants  were  also  tested  and  in- 
hibited only to ,x,30% when 800 lag were used per 50-/zl as- 
say. The only efficient, reversible inhibitors of intra-cisternal 
Golgi transport were the E329Q and the E329/D604Q mu- 
tants. 
Characterization of  Anti-NSF Monoclonal Antibodies 
Monoclonal antibodies (2C8, 2E5, and 6E6), produced by 
Tagaya et ai.  (46) have been shown to be inhibitory in the 
intra-Golgi transport assay.  One of these antibodies, 2C8, 
stimulates the ATPase activity of NSF by twofold (46). The 
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Figure 4. Inhibitory effect of ATP binding site mutants of NSF on 
iutra-Golgi transport. The effect of the ATP binding site mutants 
and rearrangement mutants of  NSF on intra-Golgi transport was de- 
termined by adding increasing amounts of the NSF mutants into a 
standard  transport  assay using untreated  membranes  and  heat- 
inactivated CliO cytosol (A). The standard intra-Golgi transport 
assay was inhibited by adding 200 ng of  mutant NSF (B, solid bars) 
and the inhibition was reversed by the addition of 2/~g of wild-type 
NSF (slashed bars). The intra-Golgi transport  assays were per- 
formed as described in Balch et al. (1), and the data represents the 
average of duplicates. 
Figure 3. ATP-binding site mutants of NSF lack ATPase activity. 
Mutant NSF proteins were assayed  for ATPase activity as described 
in Materials and Methods. The NSF specific ATP hydrolysis is 
presented as picomoles of  ADP produced per hour per micrograms 
of protein.  The NSF specific hydrolysis was determined by sub- 
tracting the NEM resistant ATPase activity from the total ATP hy- 
drolysis observed. The proteins assayed were the wild-type NSF, 
the rearrangement mutant,  N-D2-D1, and mutants  in the  ATP- 
binding site as listed in Fig. 3. Each assay was done in duplicate 
and the data represents the average and the error bars represent the 
range. 
domain rearrangement mutants were used to determine what 
region(s) of the NSF molecule is recognized by these mono- 
clonai antibodies. Epitope mapping was accomplished using 
a series of Western blots in which the same amount of each 
rearrangement mutant was blotted onto nitrocellulose and 
probed with equal dilutions of the monoclonal antibodies. 
Reactivity was judged by the intensity of irnmunodecoration 
as  detected by the enhanced chemiluminescence method. 
Two of the antibodies, 2E5 and 6E6, reacted strongly with 
constructs in which the D1-D2 domain boundary was main- 
tained (wild-type NSF and D1-D2). Additionally, these anti- 
bodies had some minor cross-reactivity with recombinant 
SEC18p. The third antibody, 2C8, reacted with all proteins 
containing the N domain (wild-type NSF, N-D1-D1, N-D2- 
D2, N-D2-D1, and N-D1) and did not react with SEC18p (or 
D1-D2). From this data it is apparent that the 2E5 and 6E6 
antibodies recognize an epitope made up of elements from 
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acts with the N domain. 
Oligomeric Nature of NSF and Its 
Functional Relevance 
Initially, NSF was suggested to be a homotetramer using ap- 
proximate but standard methods. This estimation was based 
on a sedimentation constant of 12S and a calculated Stokes 
radius of 63/~ (57). The sedimentation constant was deter- 
mined by comparison relative to known standards in a su- 
crose gradient (as was done in Table I), and the Stokes radius 
was approximately determined from sizing chromatography 
on Superose  12.  Since it is important to be certain of the 
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Figure 5. Oligomeric nature of NSE (A) Wild-type NSF was in- 
cubated  with  the  indicated  concentrations  of the  crosslinker, 
bis(sulfosuccinimidyl) suberate (BS~), quenched with glycine, and 
the products were separated by SDS-PAGE  on a 5 % acrylamide gel 
and stained with Coomassie brilliant blue. Products corresponding 
to dimers (2N) and trimers (3N) of NSF were readily seen; how- 
ever, no tetramer was detected. The molecular mass standards were 
myosin, 200 kD; B-galactosidase, 116.2 kD; phosphorylase B, 97.4 
kD; and bovine serum albumin, 66.2 kD (B) Sedimentation analy- 
sis of NSFmyc in 50 mM HepesdNaOH, pH 7.8, 100 mM NaCI, 
2  mM  mercaptoethanol,  1 mM MgC12, 0.5  mM  ATP, and  1% 
(vol/vol) glycerol. Meniscus depletion sedimentation equilibrium 
was determined at 8,000 rpm with an initial protein concentration 
of 1.7 mg/ml, 120C, scanning at 280 nm. Assuming homogeneity 
of the sample, the data points fit (correlation coefficient >0.9998) 
the curve predicted for a complex of 255,282 D (solid line), i.e., 
a trimer of 85,094 D NSF subunits. 
oligomeric state of NSF, an independent and more precise 
series of experiments was undertaken. Chemical cross-link- 
ing, used to determine the oligomeric state of several protein 
complexes (43),  was applied to NSE  Fig.  5  A  shows the 
results of an experiment in which NSF was incubated with 
the  cross-linker  bis(sulfsuccinimidyl)  suberate  (BS0.  As 
the concentration of cross-linker is increased, it is possible 
to see the accumulation of dimer (2N) and trimer (3N), but 
no tetramer was detected. The apparent molecular masses of 
the dimer and trimer were 152 and 210 kD, respectively. This 
data supports the conclusion that NSF is a trimer. 
Analytical centrifugation of NSF was used to precisely de- 
termine  the  sedimentation  coefficient and  the  molecular 
mass of the oligomer in solution. NSFmyc migrates as a sin- 
gle band with a  sedimentation coefficient, S2o.w =  12.8  + 
0.3S, in accordance with a globular protein of 250-300 kD 
mass.  No tendency to form high molecular weight aggre- 
gates was detected. The sedimentation equilibrium at 8,000 
rpm confirms the above estimate. The molecular mass of the 
recombinant  His6-NSFmyc determined  by  this  method  is 
255  d- 5 kD (correlation coefficient =  0.9998), and it is in 
perfect agreement with a trimer using the calculated subunit 
molecular mass of 85,094 D. Fig. 5 B illustrates the fit of the 
experimental data points (taken from the scanning profile at 
280 nm) with the theoretical curve for the trimeric complex 
(molecular mass  =  255,282  D).  A  similar result was ob- 
tained when NSF was analyzed (data not shown). This sam- 
ple was subjected to freezing before ultracentrifugation and 
gave a  clear indication for dissociation of the trimer.  The 
mass average for the major component was 218,600-232,700 
D, and a minor component with a minimum molecular mass 
of 80:1:10 kD. These data indicate that in solution, NSF is 
clearly a trimer. 
Although NSF must be an oligomer to be active in intra- 
Golgi transport (5), it is unknown if all of the subunits need 
to be functional for the protein to attain maximal activity. To 
address this question, mixed NSF trimers were produced in 
E. coli by coexpressing a K266A mutant with a His~ at the 
amino terminus and a myc epitope tag at the carboxy termi- 
nus together with a wild-type NSE The mixed NSF trimer 
could then be separated by Ni2+NTA agarose chromatogra- 
phy into pools that contained no K266A subunits (trimers 
that did not adhere to the resin) and those that contain at least 
one K266A mutant subunit.  Using  monoclonal antibodies 
that recognized the myc epitope (56), it is possible to show 
that in the initial pool of NSF (runthrough) does not contain 
any of the mutant subunit (Fig. 6, A and B). Trimers with 
a higher percentage of wild-type subunits eluted in the initial 
stages of the imidazole gradient, and those that were pre- 
dominantly mutant (Hisdmyc) eluted in the later portion of 
the gradient. When assayed for NSF activity, only the pool 
made up of  all wild-type subunits had any activity (Fig. 6 C). 
Thus, even the NSF trimers that elute early in the imidazole 
gradient and contain only one mutant subunit are not active. 
These data demonstrate that the coexpressed subunits as- 
sociate randomly in E. coli, and that for trimeric NSF to be 
active, all of the subunits must be functional. 
Discussion 
The data presented in this paper directly demonstrate that the 
ATPase activity of NSF is absolutely required for it to facili- 
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Figure  6.  Effect  of  mutant 
subunits on the activity of the 
NSF  trimer.  NSF  trimers 
were produced in E. coli such 
that they contained a random 
mixture  of  wild-type  NSF 
subunits  (non-His6 tagged) 
and  K266A mutant  subunits 
that contain His6 at the amino 
terminus and a myc epitope at 
the  carboxy  terminus  (see 
Materials and Methods). The 
mixed trimers were then sepa- 
rated by affinity chromatogra- 
phy  on  Ni2+NTA  agarose 
using a gradient of imidazole 
from 20-500 mM (as denoted 
in C). Aliquots (2 #1 of 1 ml) 
of each gradient fraction were 
initially analyzed by Western 
blotting  with  antibodies that 
would recognize only the mu- 
tant subunit (A) (9El0, which 
reacts with the myc epitope of 
the  HisK266Amyc subunit) 
and all forms of NSF subunits 
(B) (6E6, see text). The mu- 
tant subunit with the two re- 
combinant tags has a slightly 
higher  molecular  weight by 
SDS-PAGE. Aliquots (0.1/~1 of 1 ml) were then assayed in a standard NSF dependent intra-Golgi transport assay (50/~1) using NEM-treated 
membranes and heat-inactivated CHO cell cytosol (see Materials and Methods). A background of 1,000 cpm was subtracted from each 
data point. 
tate membrane fusion as measured by intra-Golgi transport. 
While this has been proposed (25, 42, 57), the data presented 
here is the first demonstration that NSF used ATP hydrolysis 
to  mediate  the  fusion  of  vesicle  and  target  membrane 
bilayers. We also present data arguing that each of the three 
domains of the NSF subunit has a distinct role in NSF func- 
tion. Using site-directed mutagenesis to change two distinct 
regions of the ATP-binding sites, the relative importance of 
each of the two ATP-binding sites was demonstrated. The 
ability of the first ATP-binding site to hydrolyze  ATP is abso- 
lutely required for NSF to be functional. This domain also 
accounts for the majority of the NEM-sensitive ATPase ac- 
tivity of NSE The second ATP-binding domain is required 
for trimer formation, but its ATPase activity does not appear 
to be essential  for NSF activity.  Mutants  of this domain, 
though able to support intra-Golgi transport, do so at a re- 
duced level. The amino-terminal domain is not required for 
trimer  formation,  yet its  deletion yields an inactive NSF 
trimer.  This  domain  is  recognized by the  2C8  antibody, 
which stimulates the ATPase activity of NSF (46), suggest- 
ing that the N  domain may play some regulatory role. 
The impact of the oligomeric state of NSF would greatly 
affect hypotheses regarding how NSF might facilitate mem- 
brane fusion. NSF was originally reported to be a tetramer 
based on approximate, hydrodynamic measurements (5), yet 
cross-linking experiments could only detect a trimer of NSF 
subunits.  To  resolve  this  important  point,  more  detailed 
measurements were made by analytical ultracentrifugation. 
The new data clearly show that NSF is a trimer, and they fur- 
ther demonstrate that  each of the three subunits  must be 
functional for NSF to be active. The implication is that the 
NSF subunits must be oriented in a parallel fashion, since 
that is the only way to arrange a globular trimeric protein, 
and that the mechanism of fusion must involve a concerted 
or unified action of all of three subunits according to a mech- 
anism that is asymmetric relative to the junction between 
vesicle and target membrane. 
NSF  is  a  member of a  family of ATP-binding proteins 
delineated by a  conserved 185-amino acid region encom- 
passing the ATP-binding sites (22). This family contains pro- 
teins of widely divergent function, but with some structural 
and mechanistic similarities. Where known, the proteins are 
predominantly oligomeric (NSF, trimer; p97, hexamer [34]; 
mei-1, oligomer [7]; $4,  heterooligomer [12]) and contain 
ATPase activities with high pH optima (pH 9.0, NSF [46] 
and p97133]). Each family member has one well-conserved 
ATP-binding domain (D1  or NSF),  and the family can be 
subdivided based on the presence of a  second,  less well- 
conserved ATP-binding domain (14).  Members that are in- 
volved in transcription (SUG1 [44], TBP-1 [39], MSS1 [26]), 
proteolysis ($4  [12]),  septation  (FstH  [48]),  and  meiosis 
(mei-1 [7]) contain a single ATP-binding domain. The family 
members that have two domains are thought to be involved 
in peroxisome biogenesis (PASlp [14],  PAY4p [27], PASSp 
[491), cell division (SAVp [91, VCP [21], p97 [33], CDC48p 
[15],  cm20al2p  [52])  and  secretion  (NSF  [55],  SEC18p 
[131). 
Several mutations of the well-conserved ATP-binding do- 
main (D1 in NSF) have been made for many of the proteins 
with the same result:  inactivation of the protein. When the 
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tated to glutamic acid, the resulting PASlp was unable to res- 
cue a PAS1 deletion in yeast (20). When the other conserved 
lysine (K467  equivalent to K549  in NSF) was changed to 
glutamine, the mutant PASlp was able to rescue the deletion, 
suggesting  that,  like NSF,  this ATP-binding  site does not 
have  to hydrolyze ATP to maintain an active PASlp (20). 
Mutations of the ATP-binding  site of meiq of C. elegans are 
dominant negative inhibitors of meiotic spindle formation 
(7), These examples, together with the data presented in this 
paper,  demonstrate that the ability of this conserved ATP- 
binding region (D1 in NSF) to hydrolyze ATP is essential to 
the function of the ATP-binding  protein family. A likely pos- 
sibility would be that these proteins use this conserved do- 
main as an energy transducer to convert the chemical energy 
of ATP hydrolysis into some physical force needed to carry 
out their cellular function.  By  extension of this  idea,  the 
other domains  might be  responsible  for the  specificity  of 
each protein's  interactions in the cell. 
With the identification of the SNAREs and the realization 
that they may control the specificity of transport vesicle-to- 
target membrane docking, it is now possible to make more 
meaningful speculations as to the role of NSF in facilitating 
membrane fusion.  The SNARE  hypothesis  holds that the 
vesicle  SNARE  binding  to  its  cognate  target  membrane 
SNARE is the basis for core specificity of vesicle targeting 
(4, 41, 42). The resulting docking complex is the site of the 
binding of SNAPs (or and q/), which then act to mediate the 
binding of NSF and the formation of the 20 S fusion particle 
(57). Presumably, once bound, NSF uses its ability to hydro- 
lyze ATP in some way to help initiate the fusion process. In 
vitro  experiments  using  detergent-solubilized  components 
have shown that the disassembly of the 20 S particle is trig- 
gered by ATP hydrolysis, apparently  by NSF (25,  41, 42). 
In one model of membrane fusion, this disassociation of the 
solubilized  20  S  particle  has  been  interpreted  to  be  a 
manifestation of membrane fusion.  Data presented in this 
manuscript support this idea:  ATP hydrolysis by the D1 do- 
main is absolutely  required for intra-Golgi transport  and, 
therefore, membrane fusion. Since this domain accounts for 
the majority of NSF's ATPase, it is not hard to imagine that 
it accounts for the ATP hydrolysis that drives the disassembly 
of the 20 S particle. The E329Q mutant is an efficient inhibi- 
tor of transport,  suggesting  that this  mutant  would incor- 
porate into the 20 S fusion particle and, because of its inabil- 
ity to hydrolyze ATP, fail to progress through  fusion, thus 
locking the 20 S particle into an inactive conformation. This 
model would hold that the ATPase activity of D1, which is 
essential to transport,  is in fact the energy source for mem- 
brane fusion as manifested by 20 S particle disassembly. 
What could be the role of the 132 domain? Although ATP 
hydrolysis by D2 is not necessary  for a round of fusion,  it 
is still possible that ATP hydrolysis by D2 may be needed for 
recycling NSF after fusion.  In this model,  the D1  domain 
would be responsible for driving membrane fusion, and the 
D2 domain would be involved in disassembly/recycling  of 
the fusion machine. This model is also supported by the data 
presented in this manuscript. The fact that the mutations of 
the D2 domain are able to sustain a fraction of the total trans- 
port suggests that these mutants may be able to only facilitate 
a single fusion event per NSF molecule. 
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